Dublin, Jan. 18, 2019 (GLOBE NEWSWIRE) -- The "Nicotine Addiction R&D Pipeline Analysis Report, H2-2018" report has been added to ResearchAndMarkets.com's offering. The Nicotine Addiction pipeline guide presents complete overview of drugs currently being developed for Nicotine Addiction. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Nicotine Addiction pipeline candidate. Research and Development progress along with latest news related to each of the Nicotine Addiction pipeline candidates is included. Major companies participating in therapeutic development of Nicotine Addiction are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided. Amid strong interest for cure of Nicotine Addiction from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Nicotine Addiction clinical and pre clinical products. The report assists in identifying potential upcoming companies and drugs in Nicotine Addiction pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition. Scope of Nicotine Addiction pipeline report includes

  • Panorama of Nicotine Addiction pipeline markets including statistics on therapeutic drugs and companies involved
  • Nicotine Addiction Pipeline candidates across various development phases including both pre clinical, discovery and clinical stages are covered
  • Nicotine Addiction pipeline candidates across various Mechanism of Actions' are also presented in the study
  • Overview of companies participating in Nicotine Addiction pipeline with short introduction to their businesses and pipeline projects
  • For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co developer and licensee are provided.
  • Research and Development progress and trial details, results wherever available, are also included in the pipeline study
  • The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Nicotine Addiction pipeline therapeutics

Key Topics Covered: I. Key Findings 1. Companies Investing in Nicotine Addiction Pipeline include Number of Companies with Nicotine Addiction projects in pre clinical Development Number of Companies with Nicotine Addiction projects in Clinical Development Nicotine Addiction Pipeline Companies based in Americas Nicotine Addiction Pipeline Companies based in Europe Nicotine Addiction Pipeline Companies based in Asia Pacific Nicotine Addiction Pipeline Companies based in Rest of the World 2. Pipeline Candidates include Nicotine Addiction Pipeline Agents in pre clinical/ Discovery stage of Development Nicotine Addiction Pipeline Agents in Clinical Development stage Nicotine Addiction Pipeline Therapeutic Compounds received special status Mechanism of Action of most pipeline Drugs Small molecules among the Nicotine Addiction Pipeline agents II. Insights into Nicotine Addiction Pipeline - 1. Disease Overview Introduction to Nicotine Addiction Symptoms and Causes of Nicotine Addiction Treatment or Prevention Options for Nicotine Addiction Other Details 2. Phase wise Pipeline Compounds Nicotine Addiction Pipeline Pre Clinical/ Discovery stage Drugs Nicotine Addiction Pipeline Phase 1 stage Drugs Nicotine Addiction Pipeline Phase 2 stage Drugs Nicotine Addiction Pipeline Phase 3 stage Drugs Nicotine Addiction Pipeline Pre Registration stage Drugs 3. Company wise Nicotine Addiction Pipeline Compounds 4. Nicotine Addiction Pipeline by Mechanism of Action III. Nicotine Addiction Pipeline Compound Details Drug Details 1. Snapshot Name of the Therapeutic Agent Originator Developing Company Co Developer/ License Partner Orphan Drug / Fast Track/ Designation Development Phase 2. Drug Overview 3. Mechanism of Action 4. Current Status 5. Clinical Trial Details IV. Nicotine Addiction Pipeline Company Briefs V. Latest News and Developments in Global Nicotine Addiction Pipeline Market VI. Appendix For more information about this report visit https://www.researchandmarkets.com/research/6...otine?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Addiction Disorders Drugs